These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 34448035)

  • 1. Diagnostic and prognostic values of 2-[
    Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
    Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
    Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network.
    Han S; Oh JS; Kim YI; Seo SY; Lee GD; Park MJ; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Clin Nucl Med; 2022 Jul; 47(7):590-598. PubMed ID: 35675135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of
    Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
    Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of [
    Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
    Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
    Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
    Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiparameter diagnostic model based on
    Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J
    BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of [
    Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic parameters of [
    Markus M; Sartor H; Bjurberg M; Trägårdh E
    Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral metabolic heterogeneity by
    Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J
    Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
    Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
    Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.